Anastomosis Devices Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Anastomosis Devices Market Size

Anastomosis Devices Market size is projected to showcase substantial progress between 2024 and 2032, driven by the rising number of people diagnosed with cardiovascular and gastrointestinal disorders. These devices are widely used in coronary artery bypass surgeries and help improve the functioning of the left ventricular system, thus enhancing the patient’s survival rate.
 

Patients are increasingly inclined toward non-invasive surgical procedures that use advanced technologies and devices to alleviate their medical condition and fasten the recovery time. As a result, constant technological improvements in trans-catheters and drug-eluting stents will drive the adoption of anastomosis devices.
 

Anastomosis Devices Market Trends

The technological developments undertaken by medical device firms will help enhance anastomosis devices in terms of their functioning and durability. For instance, in January 2023, Lydus Medical received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its microvascular anastomosis suture deployment system, Vesseal. The system is designed for standardized omnivessel anastomoses, allowing fast, safe, simple, and effective procedures. Similar innovations & launches will shape the industry outlook.
 

The healthcare sector globally has been facing the pinch of inflation that has already taken a toll on other businesses. Based on the Consumer Price Index captured in March 2022, healthcare costs recorded a 2% uptick. Patients feeling the crunch of rising prices have either postponed or canceled their procedures for the time being, which may negatively impact market performance. With the current situation only expected to get worse, the anastomosis devices industry could face significant consequences during the projection period. 
 

Anastomosis Devices Market Analysis

Reusable anastomosis devices segment will capture a sizeable market share by 2032, as professionals in the healthcare sector are constantly looking for ways to conduct cost-effective yet eco-friendly surgeries. Disposable devices notably increase medical wastage and the risk of contracting fatal infections. Besides, it also becomes expensive for hospitals to make new medical equipment purchases regularly. Since the number of cardiovascular surgeries is increasing every year, the demand for reusable anastomosis devices is likely to be higher than that for disposable ones.
 

The cardiovascular segment will generate notable demand through 2032. Anastomosis devices find high application in treating cardiovascular conditions as surgeons are using non-invasive techniques to carry out surgical procedures. The use of anastomosis devices can help medical professionals in performing surgeries with high precision. The procedure can create a durable and safe anastomosis even in the most intricate areas of the heart, which will propel the product usage.
 

North America anastomosis devices market size will expand at a robust rate through 2032 due to drastic changes taking place in the lifestyle of the population, such as unhealthy food habits and sedentary routines. It has resulted in growing cases of GI and cardiovascular diseases. According to the Centre for Disease Control and Prevention (CDC), approximately 805,000 people in the U.S. experience a heart attack each year. This will boost the product demand for managing disease burden in the region.
 

Anastomosis Devices Market Share

Well-known organizations involved in the production of anastomosis devices across the globe include:

• Aesdex
• Vitalitec
• Synovis Micro Companies Alliance
• B. Braun Melsungen
• Medtronic
• Medical Devices Business Services Inc.
• Novare Surgical Systems Inc.
• Ethicon
• Getinge LLC
• LivaNova
   

Anastomosis Devices Industry News  

• In January 2024, Medtronic Private Limited, a subsidiary of Medtronic plc, collaborated with Cardiac Design Labs to launch, scale up, and expand access to CDL’s new diagnostic technology, Padma Rhythms®, an ELR patch designed for long-term, comprehensive heart monitoring and diagnosis.

What Information does this report contain?